A method for precise microscopic enumeration of acid-fast bacilli in the sputum of patients with pulmonary tuberculosis is described. The total number of acid-fast bacilli and the number of culturable cell units of tubercle bacilli per milliliter of sputum were determined in 269 specimens from 28 patients collected prior to and/or during chemotherapy, to establish the usefulness of the procedure for evaluation of the effects of chemotherapy. Prior to or very early in the course of therapy, there was good agreement between microscopically and culturally measurable bacilli in 27 of 28 patients. Thereafter, there were systematic divergences in five patients and occasional divergences in most others. Yet, in general, in 20 of the 28 patients, the microscopically determined population provided a useful measure of the number of culturable tubercle bacilli present. Although the microscopic procedure does not allow species identification of mycobacteria or differentiation between viable and nonviable cells, it often provided, within hours rather than days or weeks, useful information on the residual burden of acid-fast bacilli in sputum during chemotherapy. The nature of the disease in those patients in whom microscopy failed to provide useful information is discussed.
A method for precise microscopic enumeration of acid-fast bacilli in the sputum of patients with pulmonary tuberculosis is described. The total number of acid-fast bacilli and the number of culturable cell units of tubercle bacilli per milliliter of sputum were determined in 269 specimens from 28 patients collected prior to and/or during chemotherapy, to establish the usefulness of the procedure for evaluation of the effects of chemotherapy. Prior to or very early in the course of therapy, there was good agreement between microscopically and culturally measurable bacilli in 27 of 28 patients. Thereafter, there were systematic divergences in five patients and occasional divergences in most others. Yet, in general, in 20 of the 28 patients, the microscopically determined population provided a useful measure of the number of culturable tubercle bacilli present. Although the microscopic procedure does not allow species identification of mycobacteria or differentiation between viable and nonviable cells, it often provided, within hours rather than days or weeks, useful information on the residual burden of acid-fast bacilli in sputum during chemotherapy. The nature of the disease in those patients in whom microscopy failed to provide useful information is discussed.
Cultural methods for demonstration of tubercle bacilli in sputum are both costly and timeconsuming. Such procedures often require 4 to 6 weeks or longer before results are available. Much information has been derived over the years, however, from the enumeration of tubercle bacilli according to the Gaffky scale (NTRDA Diagnostic Standards and Classification of Tuberculosis, p. 41, published by the National Tuberculosis and Respiratory Disease Association, 1969), and in 1952 Steenken et al. (17) , in a study of increased microbial drug resistance in four patients treated with hydrazines of isonicotinic acid, observed an initial fall in Gaffky counts followed by a progressive rise at a time corresponding to the onset of increased bacillary resistance. Although, as pointed out by these investigators, the reliability of the Gaffky count technique is justifiably open to question, nonetheless, when performed under controlled conditions, it often indicates unmistakable trends in bacillary content.
Recently, a precedent was established by investigators of Mycobacterium leprae who ' Present address: Pulmonary Disease Service, Denver General Hospital. Denver, Colo. 80204. showed that more quantitative microscopic enumeration of acid-fast organisms is possible and often provides useful information concerning the course of the disease (3, 13, 15, 16) . The present study was undertaken, therefore, to establish whether quantitative enumeration of tubercle bacilli in sputum by a microscopic procedure likewise would provide meaningful information with respect to patients with pulmonary tuberculosis.
Early in the study, it became apparent that differentiation between the total microbial population, as determined by microscopy, and the number of culturable cell units is frequently important.
In the present report, therefore, (i) a microscopic method for enumeration of the total number of acid-fast bacilli per milliliter of sputum will be described, (ii) evidence will be presented to show the reproducibility of data when this procedure is used and to show also the limitations of the procedure, and (iii) observations will be reported which illustrate the extent to which the microscopically determined population in the sputum parallels or deviates from the culturable number of organisms prior to and 94 on November 6, 2017 8 with moderately advanced, and 1 with minimal disease in the series. The drug regimens employed for treatment of these patients varied widely and will not be discussed herein.
A total of 269 specimens were collected from these 28 patients prior to or during the course of chemotherapy and will serve as the basis for this report.
Since the initial purpose of the study was to develop a method for microscopic enumeration of acid-fast bacilli in sputum, specimens for study were collected at random and no rigid collection schedule was established in advance. In general, however, at least early in the course of treatment, they were collected at approximately 3-to 8-day intervals.
All specimens were collected in the early morning, in graduated conical plastic tubes (Falcon Sputum Collection System Kit, Falcon Plastics Co., Oxnard, Calif.) prior to daily drug administration. In all instances, they were delivered to the Veterans' Administration Special Research Laboratory at East Orange, N.J., within 1 to 3 h after collection and, unless otherwise specified, were processed on the day of collection.
The methods employed for digestion, decontamination, and concentration of the specimens and for microscopic enumeration of acid-fast bacilli will be described below. The number of culturable cell units per milliliter of sputum was determined in the conventional manner, by the method of Fenner et al. (2) .
RESULTS
Method of microbial enumeration by microscopy. Initially, attention was directed to the development of a procedure for quantitative concentration of sputum specimens and for enumeration of the acid-fast bacilli present in specimens from tuberculous patients. Based on procedures used previously by ourselves (4) and by others (1, 11, 16) , a method was developed by one of us (A.P.H.) which basically consists of: (i) measurement of the initial volume of sputum; (ii) digestion, decontamination, and concentration of the specimens by the N-acetyl-Lcysteine method (6) In occasional instances, particularly late in the course of chemotherapy, the size of microbial population was estimated by examination of smears of the concentrated specimen (step ii, above) prior to its resuspension in sterile bovine albumin (step iii, above), and the concentrate was then suspended in only a fraction of one volume of 0.02% sterile bovine albumin (step v, above). In this manner, very small numbers of organisms at times could be detected.
It should be noted that the examination of smears made in the conventional manner and graded according to the NTRDA scale (step iii, 96 HOBBY ET AL. above) provided only a crude estimate of the actual number of acid-fast bacilli present. For example, among a group of arbitrarily selected specimens, 10 classified as containing "numerous" acid-fast bacilli by the NTRDA scale showed in fact between 1.08 x 106 and 4.02 x 107 per ml of sputum; in 10 containing "few" acid-fast bacilli by the NTRDA scale, 2.40 x 104 to 1.41 x 106 organisms per ml of sputum were detected; in 10 containing "rare" acid-fast bacilli, <7.85 x 103 to 2.99 x 105 were detected; and, in 10 showing no acid-fast bacilli on conventional smears, <7.85 x 103 to 6.78 x 10' organisms per ml of sputum were detected by the more quantitative procedure described.
The minimal number of organisms per milliliter of sputum detectable by the procedure described when 100 sight fields are examined is 7.8 x 103. This is in close agreement with the observations of Yeager et al. (20) , who found that, at the time sputum specimens became negative by microscopy, a mean of 9,500 culturable tubercle bacilli per ml of sputum could be demonstrated.
Reliability of the method. The preparation of smears by the above-described method yielded a remarkable degree of reproducibility when multiple smears of the same specimen were examined. In initial studies, four smears were prepared from single dilutions of the suspensions of each of eight sputum concentrates. As illustrated by representative data shown in Table 1 , the number of organisms detected per milliliter of sputum never varied by more than a fraction of one log. Although essentially all specimens employed in the present study were processed on the day of collection, a few were subdivided and tested both on the day of collection and again after various periods of time. Five were retested after storage at 5 C for 5 days, three were retested after 7 days, four after 8 days, and three after 21 days. Both the total number of acid-fast bacilli and the number of culturable cell units per milliliter of sputum were determined in each instance. A decrease of more than one log in the total number of acid-fast bacilli occurred on storage of only one specimen. Similarly, a decrease of more than one log in the number of culturable cell units was observed after storage of only two. Although the number of specimens tested was small, it seems probable that, when necessary, sputum may be stored at 5 C for periods up to 5 to 8 days. It must be recognized, however, that after effective chemotherapy the number of residual viable cell units may be small, drug concentration in the sputum may be high, and the antimicrobial action of the drugs under such conditions may continue in vitro.
Comparison of microscopically detectable acid-fast bacilli and culturable microbial cell units in sputum prior to and during chemotherapy. The total number of microscopically detectable mycobacteria and the number of culturable cell units per milliliter in 269 sputum specimens from 28 patients have been determined by the methods described. In all instances, the sputum concentrate suspensions were inoculated onto Middlebrook 7H11 Agar for enumeration of the culturable tubercle bacilli simultaneously with preparation of smears for microscopic study.
As shown in Tables 2 and 3 , prior to initiation of chemotherapy and/or during the first 1 to 5 days after start of chemotherapy, the number of microscopically detectable acid-fast organisms and the number of culturable cell units per milliliter of sputum closely approximated each other. As chemotherapy continued, however, the number of culturable cell units at times differed from the total number of organisms present, and it became apparent that the observed results may relate to some degree to the nature and extent of disease at the start of chemotherapy.
Results in patients with far advanced pulmonary tuberculosis. Of the 28 patients in the study, 19 had far advanced pulmonary tuberculosis. The number of microscopically detected acid-fast bacilli in the sputum of 5 of these 19 patients (no. 1 to 5) remained high throughout periods of observation which ranged from 52 to more than 151 days. In contrast, the number of culturable cell units began to decrease soon after the start of chemotherapy and ultimately deviated widely from the total number of organisms detected by microscopy ( Table 2 ). In none of these patients did the microscopic count fall and remain consistently below easily detectable numbers, although the number of culturable cell units decreased steadily. Reliance on b INH, isoniazid, 300 mg; EMB, ethambutol, 600 to 800 mg except in patients 3, 10, and 15, who received 900, 900, and 1,000 mg, respectively; PZA, pyrazinamide, 2 g in patient 10, 1.5 g in patient 4, and 0.5 g in patient 2; RMP, rifampin, 450 mg in patients 11 and 17, 600 mg in patients 2, 3, 9, 10, 14, and 16, 750 mg in patients 1, 6, 8, 9, 12, and 15; each orally once daily. SM, streptomycin 1 g daily by the intramuscular route.
c Indicates specimens in which the number of culturable cell units and the total number of cells detected by microscopy deviated by more than 1.5 logs.
d At 261 and 265 days after start of treatment, patients 2 (R.B.) and 3 (C.A.), respectively, still showed 3.1 x 10' and 1.3 x 10' microscopically detectable acid-fast bacilli per ml of sputum, although no culturable cell units had been observed for more than 3 to 4 months. In patient 4 (J.S.), the number of microscopically detected acid-fast bacilli for the first time fell below 1.6 microscopic observations to establish the residual burden of acid-fast bacilli in these patients was not possible and, although adequate data are not available to state this conclusively, it is suggested that failure to observe approximately a 1.5 log decrease in the number of microscopically detectable organisms within 7 to 28 days after initiation of chemotherapy may be accepted as presumptive evidence that microscopic counts cannot be relied upon to establish the effectiveness of the drug regimens employed.
In the sputum from 13 of the 19 patients with far advanced pulmonary tuberculosis (no. 6 to 18), the number of microscopically detectable acid-fast bacilli decreased to an undetectable number within approximately 1 to 3 months after the start of chemotherapy. The number of culturable cell units of tubercle bacilli per ml of sputum in like manner decreased to a level equal to or less than 101 within a comparable period of time. Although the microscopic count was significantly higher (i.e., there was a more than 1.5 log difference) in one to four specimens from each of 11 of these patients, there was no evidence of a persistent divergence between the total and the culturable numbers, and in general the number of microscopically detectable organisms seemed to be a true reflection of the number of culturable cell units present (Table  2) .
Nine specimens from one patient (no. 19) failed to show the presence of any culturable tubercle bacilli. The number .of acid-fast bacilli detectable by microscopy 2 days after the start of chemotherapy was 1.8 x 107, however, and decreased gradually to an undetectable number in less than 8 weeks. This represents a presumably rare situation in which reliance must be placed on microscopic observations to indicate the effects of chemotherapy ( Table 2) .
The important difference(s) between patients 1 to 5 and 6 to 18 is unclear at present. The presence of extensive exudative disease in all lobes with cavities in multiple lobes may be contributing factors. It is our belief, however, that the size of the acid-fast burden prior to start of chemotherapy (average, 9.5 x 107 in patients 1 to 5 versus 2.6 x 106s in patients 6 to 18, per ml of sputum) may be of prime importance, for unquestionably higher drug concentrations would be required for full effectiveness in the first group. That the drug regimens employed were effective is clear from the observed decreases in the residual numbers of culturable bacilli, but no information is available to indicate whether the nonculturable acidfast cells, detectable only by microscopy, are in fact dead organisms.
Results in patients with moderately advanced or minimal pulmonary tuberculosis. Nine patients had only moderately advanced or minimal pulmonary tuberculosis. In these, the initial burden of culturable acid-fast bacilli prior to or soon after start of chemotherapy ranged from 103 to 5.6 x 106 (average, 1.5 x 106).
In the sputum of seven of these nine patients (no. 20 to 26), the numbers of culturable and microscopically detected acid-fast bacilli closely approximated each other throughout the observation period (Table 3 ). In general, the microscopic counts well reflected the number of culturable cell units present. In one patient only (no. 25), acid-fast bacilli were still detected at the end of the observation period (i.e., at 41 days), and the steady decline in this patient from 7.4 x 106 to 2.6 x 10 organisms per ml of sputum suggested that an undetectable level would have been achieved if foltow-up specimens had been available 1 to 2 weeks later.
The total number of acid-fast bacilli in the other two patients (no. 27 and 28) was less than the minimal detectable number prior to and during chemotherapy. This was consistent with the small number of culturable tubercle bacilli found on culture of these specimens. Based only on the bacteriological findings, it was clear that these patients had little disease and represented ones in whom cultural methods must be used for measurement of the residual burden of tubercle bacilli during chemotherapy (Table 3) .
Emergence of microbial drug resistance. In three patients (no. 17, 18, and 26), the number of organisms detectable by microscopic examination of 300 sight fields gradually decreased upon initiation of chemotherapy to less than the minimal detectable number (i.e., to <2.6 x 103). The number of culturable cell units per ml of sputum in two of these three patients (i.e., in no. 17 and 26) simultaneously decreased to 2.0 x 101 and 8.0 x 101, respectively, but ultimately rose, and emergence of isoniazid resistance seemed likely. In the third patient (no. 18), the number of culturable cell units per milliliter of sputum failed to decrease significantly, and emergence of microbial resistance to isoniazid was apparent by 40 days after the start of chemotherapy. The initial susceptibility of these three strains to less than 0.5 ,g of isoniazid per ml of medium had been clearly demonstrated by conventional indirect susceptibility tests performed by us prior to the start of treatment. Two of the three patients (no. 26 and 18) received isoniazid and ethambutol only, whereas one (no. 17) was treated with isoniazid and rifampin (Tables 2 and 3 ). In two of the three patients (no. 17 and 26), emergence of At that time, the procedure for microscopic enumeration of tubercle bacilli was briefly described. Further, based on the limited data then available, the conclusion was drawn that, although it does not allow species identification of mycobacteria and does not permit differentiation between viable and nonviable cells, the procedure does offer the advantage of providing in hours, rather than days or weeks, useful information on the burden of acid-fast bacilli in some patients prior to and during chemotherapy.
The data presented in the present report, which have been derived from study of 269 sputum specimens from 28 patients with pulmonary tuberculosis, confirm our initial findings. In the specimens from 20 of the 28 patients, despite occasional divergences, the number of acid-fast bacilli detected microscopically closely approximated the number of culturable mycobacterial cell units. Thus, the microscopic observations provided a useful measure of the residual microbial burden, for even the elimination of 3 weeks of incubation can be a significant saving at times.
No information is available at present to characterize clearly the patients in whom full reliance must be placed on cultural data. In those with minimal disease, the total acid-fast population per milliliter of sputum may be small, and the number of organisms may be less than the minimal number detectable by microscopy. In such instances, only cultural data obviously are meaningful. Of greater importance, however, are those in whom the total number of microscopically detectable acid-fast bacilli remains consistently high for days or weeks after the number of culturable tubercle bacilli has decreased. In the present study, five patients fell into this category. The important difference between these five and the others 102 HOBBY ET AL.
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on November 6, 2017 by guest http://aac.asm.org/ Downloaded from studied to date is unclear, but it is of interest that, in those three on whom pretreatment data are available, the total number of culturable acid-fast bacilli per ml of sputum prior to start of chemotherapy ranged from 7.0 x 107 to 2.5 x 108 (mean, 1.4 x 108). In contrast, in those other patients with far advanced disease on whom pretreatment data are available, the initial number of culturable acid-fast bacilli per ml of sputum ranged from 9.8 x 104 to 3.6 x 106 (mean, 1.3 x 106). It may be that those patients in whom the total number of acid-fast bacilli per ml of sputum exceeds 107 to 5.0 x 107 prior to initiation of chemotherapy are the ones in whom reliance must be placed, at least initially, on cultural data. As indicated previously, pretreatment specimens unfortunately were not obtained from all patients in the study. Further specimens were not obtained at uniform intervals during chemotherapy. These deficiencies preclude precise determination of the magnitude and rate of decrease in microbial population that occurred during chemotherapy. It is important to note, however, that a more than one log decrease in the culturable population per milliliter of sputum was observed in 19 of 27 patients within 14 days or less after start of treatment. The average observed time for a decrease of this magnitude in the 27 patients was only 12.5 days. Further, a two log (or greater) decrease in the culturable population occurred in 22 of the 27 patients within 28 days (average observed time, 15.6 days).
Two weeks or less of chemotherapy have long been accepted by many investigators as an insignificant amount. Others have emphasized the speed with which antimicrobial effects become apparent in vitro, after initial drug-parasite contact, and have suggested that the same rapid action may occur in vivo. The data presented herein, for the first time, clearly establish that there is, in fact, a very significant decrease in the acid-fast burden in at least some patients during the first 2 weeks of chemotherapy. Whereas all 28 patients received isoniazid (300 mg) once daily throughout this initial 14-day period, only 17 received rifampin during part or all of that time, and there is no indication that any one drug or drug regimen was responsible for the observed prompt response.
A single patient (no. 17) was previously described by us (Transactions of the Veterans' Administration-Armed Forces Conference on Pulmonary Disease Research, 1972) in whom emergence of microbial resistance to isoniazid was demonstrated by an upward surge in microscopic count after an initial gradual decrease in the number of organisms per milliliter of sputum. Two other patients (no. 18 and 26) in whom emergence of microbial drug resistance was detected are described herein, and it seems apparent that acceptance of the probable significance of increasing numbers of microscopically detectable cells may lead at times to more prompt adjustment of drug regimens than is possible when one must wait for the appearance of microbial growth.
Finally, the ease with which small numbers of culturable cell units of tubercle bacilli have been detected when specimens are digested, concentrated, and cultured by the quantitative procedures described warrants consideration. Persistence of small numbers of culturable organisms, frequently representing far less than 0.01% of the original population, has been clearly demonstrated, perhaps for the first time in humans (see patients 16, 20, 24 , and 28). The persistence of such organisms, after long-term chemotherapy of infected animals, was the subject of extensive study by McDermott (7, 8) , who has called attention to their importance in relation to relapse and ultimate outcome of therapy of tuberculous patients.
Throughout the present study, reliance has been placed on acid-fastness as a guide to the microscopic detection of tubercle bacilli. In 1953, however, Koch-Weser et al. . (5) demonstrated that mycobacteria may lose acid-fastness in the presence of isoniazid. Since all of our patients received daily isoniazid for chemotherapy, one might assume that many of the infecting organisms would have lost acid-fastness. Yet the microscopic counts were high enough to suggest that this may not have occurred.
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